Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (11): 966-972.doi: 10.35541/cjd.20201069
• Original Articles • Previous Articles Next Articles
Chen Lijun, Li Tingting, Zhao Juan, Zeng Ying, Wang Peng, Kang Xiaojing
Received:
2020-11-05
Revised:
2021-08-27
Online:
2021-11-15
Published:
2021-11-01
Contact:
Kang Xiaojing
E-mail:drkangxj666@163.com
Supported by:
Chen Lijun, Li Tingting, Zhao Juan, Zeng Ying, Wang Peng, Kang Xiaojing. Screening of DNA methylation sites associated with melanoma and construction of an aberrant methylation profile: a preliminary study[J]. Chinese Journal of Dermatology, 2021, 54(11): 966-972.doi:10.35541/cjd.20201069
[1] | Moran B, Silva R, Perry AS, et al. Epigenetics of malignant melanoma[J]. Semin Cancer Biol, 2018,51:80⁃88. doi: 10.1016/j.semcancer.2017.10.006. |
[2] | Chatterjee A, Stockwell PA, Ahn A, et al. Genome⁃wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis[J]. Oncotarget, 2017,8(4):6085⁃6101. doi: 10.18632/oncotarget. 14042. |
[3] | Wouters J, Vizoso M, Martinez⁃Cardus A, et al. Comprehensive DNA methylation study identifies novel progression⁃related and prognostic markers for cutaneous melanoma[J]. BMC Med, 2017,15(1):101. doi: 10.1186/s12916⁃017⁃0851⁃3. |
[4] | de Unamuno Bustos B, Murria Estal R, Pérez Simó G, et al. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma[J]. Br J Dermatol, 2018,179(2):394⁃404. doi: 10. 1111/bjd.16254. |
[5] | 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)黑素瘤诊疗指南2017.V1[M]. 北京: 人民卫生出版社, 2017:1⁃111. |
[6] | 何纯刚, 黄沁园, 钟世彪, 等. 结直肠腺瘤基因低甲基化谱分析及其标记物的筛选研究[J]. 结直肠肛门外科, 2018,24(1):1⁃5. doi: 10.19668/j.cnki.issn1674⁃0491.2018.01.001. |
[7] | Rosko AJ, Vankoevering KK, McLean SA, et al. Contemporary management of early⁃stage melanoma: a systematic review[J]. JAMA Facial Plast Surg, 2017,19(3):232⁃238. doi: 10.1001/ jamafacial.2016.1846. |
[8] | 吴海竞, 付思祺, 李倩文, 等. 黑色素瘤的生物标志物:从基因组学到表观遗传学[J]. 协和医学杂志, 2018,9(1):60⁃68. doi: 10.3969/j.issn.1674⁃9081.2018.01.012. |
[9] | 郭芳, 康晓静, 唐小辉, 等. 新疆80例恶性黑素瘤BRAF基因突变分析[J]. 中华皮肤科杂志, 2013,46(1):33⁃36. doi: 10. 3760/cma.j.issn.0412⁃4030.2013.01.013. |
[10] | Chen YA, Lemire M, Choufani S, et al. Discovery of cross⁃reactive probes and polymorphic CpGs in the illumina infinium human methylation 450 microarray[J]. Epigenetics, 2013,8(2):203⁃209. doi: 10.4161/epi.23470. |
[11] | Conway K, Edmiston SN, Khondker ZS, et al. DNA⁃methylation profiling distinguishes malignant melanomas from benign nevi[J]. Pigment Cell Melanoma Res, 2011,24(2):352⁃360. doi: 10.1111/j.1755⁃148X.2011.00828.x. |
[12] | Hallberg AR, Vorrink SU, Hudachek DR, et al. Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma[J]. Epigenetics, 2014,9(12):1641⁃1647. doi: 10.4161/15592294. 2014.988062. |
[13] | Mosavi LK, Cammett TJ, Desrosiers DC, et al. The ankyrin repeat as molecular architecture for protein recognition[J]. Protein Sci, 2004,13(6):1435⁃1448. doi: 10.1110/ps.03554604. |
[14] | Hughey CC, Trefts E, Bracy DP, et al. Glycine N⁃methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates[J]. J Biol Chem, 2018,293(30):11944⁃11954. doi: 10.1074/jbc.RA118.002568. |
[15] | Greenhalgh CJ, Rico⁃Bautista E, Lorentzon M, et al. SOCS2 negatively regulates growth hormone action in vitro and in vivo[J]. J Clin Invest, 2005,115(2):397⁃406. doi: 10.1172/JCI 22710. |
[16] | Van Den Eynde BJ, Gaugler B, Probst⁃Kepper M, et al. A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription[J]. J Exp Med, 1999,190(12):1793⁃1800. doi: 10.1084/jem.190.12.1793. |
[17] | G·B·特伦布利, A·N·莫莱提斯, M·菲利翁, 等. 用于通过使用肾相关抗原1(KAAG1)的抑制剂来治疗三阴性乳癌和基底样乳癌的方法[P]. 中国专利: CN104955477B.2020⁃03⁃03 . |
[18] | Yamaki A, Akiyama R, Murakami C, et al. Diacylglycerol kinase α⁃selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines[J]. J Cell Biochem, 2019,120(6):10043⁃10056. doi: 10.1002/jcb.28288. |
[19] | Serrano A, Tanzarella S, Lionello I, et al. Rexpression of HLA class I antigens and restoration of antigen⁃specific CTL response in melanoma cells following 5⁃aza⁃2′⁃deoxycytidine treatment[J]. Int J Cancer, 2001,94(2):243⁃251. doi: 10.1002/ijc.1452. |
[20] | Seberg HE, Van Otterloo E, Loftus SK, et al. TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF[J]. PLoS Genet, 2017,13(3):e1006636. doi: 10.1371/journal.pgen. 1006636. |
[21] | Wang T, Abou⁃Ouf H, Hegazy SA, et al. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients[J]. J Mol Med (Berl), 2016,94(12):1411⁃1422. doi: 10.1007/s00109⁃016⁃1458⁃4. |
[22] | Babina IS, McSherry EA, Donatello S, et al. A novel mechanism of regulating breast cancer cell migration via palmitoylation⁃dependent alterations in the lipid raft affiliation of CD44[J]. Breast Cancer Res, 2014,16(1):R19. doi: 10.1186/bcr3614. |
[23] | Lissa D, Ishigame T, Noro R, et al. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients[J]. Lung Cancer, 2018,122:151⁃159. doi: 10.1016/j.lungcan.2018.05.021. |
[24] | Park SM, Choi EY, Bae M, et al. A long⁃range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients[J]. Clin Epigenetics, 2017,9:73. doi: 10.1186/s13148⁃017⁃0373⁃z. |
[25] | Zhou C, Li J, Li Q, et al. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma[J]. J Clin Lab Anal, 2019,33(5):e22873. doi: 10. 1002/jcla.22873. |
[26] | Gao L, van den Hurk K, Moerkerk P, et al. Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy[J]. J Invest Dermatol, 2014,134(12):2957⁃2966. doi: 10.1038/jid.2014.270. |
[27] | Marini A, Mirmohammadsadegh A, Nambiar S, et al. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma[J]. J Invest Dermatol, 2006,126(2):422⁃431. doi: 10.1038/sj.jid.5700073. |
[28] | Vojta A, Samaržija I, Bočkor L, et al. Glyco⁃genes change expression in cancer through aberrant methylation[J]. Biochim Biophys Acta, 2016,1860(8):1776⁃1785. doi: 10.1016/j.bbagen. 2016.01.002. |
[29] | Gao L, Smit MA, van den Oord JJ, et al. Genome⁃wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma[J]. Pigment Cell Melanoma Res, 2013,26(4):542⁃554. doi: 10.1111/pcmr.12096. |
[1] | Pei Lu, Zheng Nana, Zeng Rong, Xie Yuanyuan, Xu Haoxiang, Duan Zhimin, Liu Yuzhen, Li Min, . Molecular mechanisms underlying the inflammatory response induced by Cutibacterium acnes biofilms in keratinocytes [J]. Chinese Journal of Dermatology, 2024, 57(4): 302-308. |
[2] | Wu Yubing, Wang Xiaoyu, An Binyi, Wu Yingying, Sang Hong, Kong Qingtao, . Role of cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes signaling pathway in the occurrence of psoriasis [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230394-e20230394. |
[3] | Dong Dong, Liu Tianyi. Cell metabolism and metastasis of cutaneous malignant melanoma [J]. Chinese Journal of Dermatology, 2023, 56(9): 878-881. |
[4] | Sun Linbo, Xu Jiaosheng. Curry-Jones syndrome: the first case reported in China [J]. Chinese Journal of Dermatology, 2023, 56(7): 626-629. |
[5] | Wang Yuanli, Liu Ling, Sun Zhongbin, Li Kai. Analysis of 141 cases clinically misdiagnosed as melanoma [J]. Chinese Journal of Dermatology, 2023, 56(3): 244-246. |
[6] | Li Fang, Wang Xiaoqing, Liu Mengxi, Jiang Jiayi, Huang Shudai, Wang Daguang. Research advances in recurrent melanocytic nevus [J]. Chinese Journal of Dermatology, 2023, 0(2): 20220431-e20220431. |
[7] | Li Tingting, Kang Xiaojing. Gut microbiota and immune checkpoint inhibitor treatment of melanoma [J]. Chinese Journal of Dermatology, 2023, 56(2): 177-180. |
[8] | Qiao Jiaxi, Chen Yao, Du Kun, Chen Liuqing, Chen Jinbo, Wei Li. A preliminary study on the inhibitory effect of gallic acid on the growth of human keloid fibroblasts by the transforming growth factor-β/Sma- and Mad-related proteins signaling pathway [J]. Chinese Journal of Dermatology, 2023, 56(12): 1138-1145. |
[9] | Cao Meng, Hong Anlan, Wang Yan, Fang Fang. Clinical progress in pediatric melanoma [J]. Chinese Journal of Dermatology, 2023, 56(11): 1074-1078. |
[10] | Ainiwaer·Talifu, Xiong Cheng, Refuhati·Saimaiti, Yusufu·Maitinuer, Tuerxun·Wufuer, Akenmujiang·Aierken, Julaiti·Abuduwayiti, Maimaitiaili·Kade. Screening and analysis of differentially expressed genes in vitiligo using bioinformatics methods [J]. Chinese Journal of Dermatology, 2022, 55(5): 421-425. |
[11] | Gao Ni, Liu Yu, Wang Lei, Liu Ling, Gao Tianwen, Li Kai . Clinical and histopathological analysis of five cases of solitary dermal melanoma [J]. Chinese Journal of Dermatology, 2022, 55(5): 408-410. |
[12] | Qin Shichun, Li Mengjie, Lu Xiaoyun, Xiao Fengli. Transcriptomics in atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 365-369. |
[13] | Li Yan, Zhang Xuanfen, Zhang Wenfang. Exploration of the effect of EphB2 inhibitors on cutaneous squamous cell carcinoma and their mechanisms of action based on Wnt/β-catenin signaling pathway [J]. Chinese Journal of Dermatology, 2022, 55(4): 321-328. |
[14] | Li Tingting, Zhao Juan, Wang Peng, Liu Dongmei, Kang Xiaojing. Effect of azacitidine on HOXA9 gene expression and biological behaviors of A375 melanoma cells [J]. Chinese Journal of Dermatology, 2022, 55(10): 858-863. |
[15] | Guo Wei, Zhao Tao, Guo Weinan, Ma Cuiling, Gao Tianwen, Zhao Jianhong, Li Bing. Surgical treatment strategies and outcomes of early-stage nail apparatus melanoma: a retrospective analysis of 115 cases [J]. Chinese Journal of Dermatology, 2021, 54(9): 777-784. |